BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30387014)

  • 1. Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.
    Zajkowska M; Lubowicka E; Fiedorowicz W; Szmitkowski M; Jamiołkowski J; Ławicki S
    Pathol Oncol Res; 2019 Oct; 25(4):1477-1486. PubMed ID: 30387014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer.
    Zajkowska M; Lubowicka E; Malinowski P; Szmitkowski M; Ławicki S
    Acta Biochim Pol; 2018 Dec; 65(4):621-628. PubMed ID: 30543720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.
    Zajkowska M; Głażewska EK; Będkowska GE; Chorąży P; Szmitkowski M; Ławicki S
    Mediators Inflamm; 2016; 2016():5962946. PubMed ID: 27445439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve.
    Zajkowska M; Gacuta E; Kozłowska S; Lubowicka E; Głażewska EK; Chrostek L; Szmitkowski M; Pawłowski P; Zbucka-Krętowska M; Ławicki S
    Adv Med Sci; 2019 Mar; 64(1):1-8. PubMed ID: 30227310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
    Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
    World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Biomarkers; 2017 Mar; 22(2):157-164. PubMed ID: 27775427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?
    Zajkowska M; Gacuta E; Lubowicka E; Szmitkowski M; Ławicki S
    Acta Biochim Pol; 2020 Mar; 67(1):25-29. PubMed ID: 32160452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factors a, C and d in human breast tumors.
    Gisterek I; Matkowski R; Lacko A; Sedlaczek P; Szewczyk K; Biecek P; Halon A; Staszek U; Szelachowska J; Pudelko M; Bebenek M; Harlozinska-Szmyrka A; Kornafel J
    Pathol Oncol Res; 2010 Sep; 16(3):337-44. PubMed ID: 19821158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
    Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
    Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
    Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
    Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
    Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
    Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
    Chen C; Chen Q; Dong Y; Liu X
    Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.
    Ławicki S; Będkowska GE; Szmitkowski M
    Growth Factors; 2013 Jun; 31(3):98-105. PubMed ID: 23688065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients.
    Lubowicka E; Przylipiak A; Zajkowska M; Piskór BM; Malinowski P; Fiedorowicz W; Ławicki S
    Biomed Res Int; 2018; 2018():2124390. PubMed ID: 30151375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vascular endothelial growth factors A and C in patients undergoing prostatic biopsy and TURP for suspected prostatic neoplasia.
    Singh A; Gautam KA; Dalela D; Sankhwar S; Natu S; Sankhwar P; Srivastava A
    Asian Pac J Cancer Prev; 2013; 14(3):2053-8. PubMed ID: 23679318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma levels of tissue factor as a valuable diagnostic biomarker with relevant efficacy for prediction of breast cancer morbidity.
    Zarychta E; Rhone P; Bielawski K; Rosc D; Szot K; Zdunska M; Ruszkowska-Ciastek B
    J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of VEGF-C, VEGF-D and VEGFR-3 levels combined with serum TSH in diagnosis of papillary thyroid carcinoma].
    Huang J; Li Y; Xue G; Zhang W; Li S; Zhang J; Wu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1814-7, 1821. PubMed ID: 25537909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
    Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.